title: Targeting of the VEGF-kinase inhibitor PTK787 to angiogenic vasculature using RGD-equipped albumin carrier molecules.
authors: Department of Pharmacokinetics and Drug Delivery, Groningen University Institute of Drug Exploration, Antonius Deusinglaan 1, Groningen, The Netherlands. k.temming@rug.nl <k.temming@rug.nl>
authors: K
authors: K
authors: Temming
authors: M
authors: M
authors: Lacombe
authors: H E
authors: HE
authors: Moorlag
authors: S A
authors: SA
authors: Asgeirsdottir
authors: L
authors: L
authors: Orfi
authors: G
authors: G
authors: Kéri
authors: K
authors: K
authors: Poelstra
authors: G
authors: G
authors: Molema
authors: R J
authors: RJ
authors: Kok
mesh_terms: D000418:Albumins / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D001667:Binding, Competitive; D002478:Cells, Cultured; D004337:Drug Carriers; D016503:Drug Delivery Systems / Q000379:methods*; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D010793:Phthalazines / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D011725:Pyridines / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D000418:Albumins; D004337:Drug Carriers; D009842:Oligopeptides; D010793:Phthalazines; D011725:Pyridines; D042461:Vascular Endothelial Growth Factor A; C404768:vatalanib; C047981:arginyl-glycyl-aspartic acid